135 related articles for article (PubMed ID: 20381611)
21. Risk factors for piperacillin/tazobactam-resistant Escherichia coli in ICU patients: a clinical study.
Mohammedi I; Ploin D; Duperret S; Chapuis F; Petit P
Intensive Care Med; 2003 Jul; 29(7):1164-8. PubMed ID: 12774156
[TBL] [Abstract][Full Text] [Related]
22. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
[TBL] [Abstract][Full Text] [Related]
23. Proteomic analysis of the sarcosine-insoluble outer membrane fraction of Pseudomonas aeruginosa responding to ampicilin, kanamycin, and tetracycline resistance.
Peng X; Xu C; Ren H; Lin X; Wu L; Wang S
J Proteome Res; 2005; 4(6):2257-65. PubMed ID: 16335974
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic changes in a laboratory-derived ertapenem-resistant Escherichia coli strain.
Santos KV; Carvalho MA; Martins WA; Andrade HM; Veloso LC; Coutinho SC; Bahia JL; Andrade JP; Apolonio AC; Diniz CG; Nicoli JR; Farias LM
J Chemother; 2011 Jun; 23(3):135-9. PubMed ID: 21742581
[TBL] [Abstract][Full Text] [Related]
25. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis.
Yamanaka M; Hara K; Kudo J
Appl Environ Microbiol; 2005 Nov; 71(11):7589-93. PubMed ID: 16269810
[TBL] [Abstract][Full Text] [Related]
26. Evaluating the ototoxicity of topical piperacillin-tazobactam.
Jang CH; Park H; Cho YB; Choi CH
Int J Pediatr Otorhinolaryngol; 2008 Dec; 72(12):1815-21. PubMed ID: 18845345
[TBL] [Abstract][Full Text] [Related]
27. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
Sader HS; Tosin I; Sejas L; Miranda E
Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
[TBL] [Abstract][Full Text] [Related]
28. Signature gene expression profile of triclosan-resistant Escherichia coli.
Yu BJ; Kim JA; Pan JG
J Antimicrob Chemother; 2010 Jun; 65(6):1171-7. PubMed ID: 20410062
[TBL] [Abstract][Full Text] [Related]
29. Detection of Piperacillin-Tazobactam-Resistant/Pan-β-Lactam-Susceptible Escherichia coli with Current Automated Susceptibility Test Systems.
Monogue ML; Tanner LK; Brecher SM; Aslanzadeh J; Nicolau DP
Infect Control Hosp Epidemiol; 2017 Mar; 38(3):379-380. PubMed ID: 28069100
[No Abstract] [Full Text] [Related]
30. Pharmacokinetic-pharmacodynamic modelling of the in vitro antiinfective effect of piperacillin-tazobactam combinations.
Dalla Costa T; Nolting A; Rand K; Derendorf H
Int J Clin Pharmacol Ther; 1997 Oct; 35(10):426-33. PubMed ID: 9352391
[TBL] [Abstract][Full Text] [Related]
31. Protective effect of citropin 1.1 and tazobactam-piperacillin against oxidative damage and lethality in mice models of gram-negative sepsis.
Ghiselli R; Silvestri C; Cirioni O; Kamysz W; Orlando F; Calcinari A; Kamysz E; Casteletti S; Rimini M; Tocchini M; Giacometti A; Guerrieri M
J Surg Res; 2011 Dec; 171(2):726-33. PubMed ID: 20605608
[TBL] [Abstract][Full Text] [Related]
32. Global comparison of the membrane subproteomes between a multidrug-resistant Acinetobacter baumannii strain and a reference strain.
Siroy A; Cosette P; Seyer D; Lemaître-Guillier C; Vallenet D; Van Dorsselaer A; Boyer-Mariotte S; Jouenne T; Dé E
J Proteome Res; 2006 Dec; 5(12):3385-98. PubMed ID: 17137340
[TBL] [Abstract][Full Text] [Related]
33. Population analysis of Escherichia coli isolates with discordant resistance levels by piperacillin-tazobactam broth microdilution and agar dilution testing.
Shubert C; Slaughter J; Creely D; van Belkum A; Gayral JP; Dunne WM; Zambardi G; Shortridge D
Antimicrob Agents Chemother; 2014; 58(3):1779-81. PubMed ID: 24342642
[TBL] [Abstract][Full Text] [Related]
34. Outer membrane proteomics of kanamycin-resistant Escherichia coli identified MipA as a novel antibiotic resistance-related protein.
Li H; Zhang DF; Lin XM; Peng XX
FEMS Microbiol Lett; 2015 Jun; 362(11):. PubMed ID: 25940639
[TBL] [Abstract][Full Text] [Related]
35. Heteroresistance to Piperacillin-Tazobactam in Clinical Isolates of Escherichia coli Sequence Type 131.
Rodríguez-Villodres Á; Ortiz de la Rosa JM; Álvarez-Marín R; Pachón J; Aznar J; Lepe JA; Smani Y
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061749
[No Abstract] [Full Text] [Related]
36. All genomic mutations in the antimicrobial surfactant-resistant mutant, Escherichia coli OW66, are involved in cell resistance to surfactant.
Nakata K; Koh MM; Tsuchido T; Matsumura Y
Appl Microbiol Biotechnol; 2010 Aug; 87(5):1895-905. PubMed ID: 20480162
[TBL] [Abstract][Full Text] [Related]
37. Quantitative protein expression and cell surface characteristics of Escherichia coli MG1655 biofilms.
Mukherjee J; Ow SY; Noirel J; Biggs CA
Proteomics; 2011 Feb; 11(3):339-51. PubMed ID: 21268264
[TBL] [Abstract][Full Text] [Related]
38. Effect of manuka honey on the expression of universal stress protein A in meticillin-resistant Staphylococcus aureus.
Jenkins R; Burton N; Cooper R
Int J Antimicrob Agents; 2011 Apr; 37(4):373-6. PubMed ID: 21349691
[TBL] [Abstract][Full Text] [Related]
39. Proteomics for Drug Resistance on the Food Chain? Multidrug-Resistant Escherichia coli Proteomes from Slaughtered Pigs.
Ramos S; Silva N; Hébraud M; Santos HM; Nunes-Miranda JD; Pinto L; Pereira JE; Capelo JL; Poeta P; Igrejas G
OMICS; 2016 Jun; 20(6):362-74. PubMed ID: 27310477
[TBL] [Abstract][Full Text] [Related]
40. Sub-Inhibitory Concentration of Piperacillin-Tazobactam May be Related to Virulence Properties of Filamentous Escherichia coli.
de Andrade JP; de Macêdo Farias L; Ferreira JF; Bruna-Romero O; da Glória de Souza D; de Carvalho MA; dos Santos KV
Curr Microbiol; 2016 Jan; 72(1):19-28. PubMed ID: 26364189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
